J D Brandman
Psychiatric/Mental Health · Honolulu, HINPI 1336100049
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $49,537 of the $63,363 with a category attached, or 78.2%. 14 manufacturers reported payments, led by AbbVie at 49.1% of the total. Reporting peaked in 2023 at $19,028 and has fallen 54.0% since, to $8,750 in 2025. Among psychiatric/mental health clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $257.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$31K
- Otsuka America Pharmaceutical, Inc.$16K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$8K
- Teva Pharmaceuticals USA, Inc.$5K
- Neurocrine Biosciences, Inc.$2K
- E.r. Squibb & Sons, L.L.C.$504
- plus $1K from 8 others
What the payments were for
- Speaking & faculty fees$49,53778%
- Travel & lodging$2,3444%
- Food & beverage$11,41518%
- Education$670%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 68 | $31,089 |
| Otsuka America Pharmaceutical, Inc. | 56 | $15,587 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $7,583 |
| Teva Pharmaceuticals USA, Inc. | 19 | $4,820 |
| Neurocrine Biosciences, Inc. | 27 | $2,468 |
| E.r. Squibb & Sons, L.L.C. | 8 | $504 |
| Alkermes, Inc. | 11 | $337 |
| Axsome Therapeutics, Inc. | 4 | $317 |
| Sunovion Pharmaceuticals Inc. | 10 | $186 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $142 |
| Sage Therapeutics, LLC | 1 | $110 |
| Vanda Pharmaceuticals Inc. | 1 | $104 |
| Avanir Pharmaceuticals, Inc. | 4 | $78 |
| GSK | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$63,363 in reported general payments places this provider in the 95th percentile of 103 psychiatric/mental health providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 64 | $101,363 |
| RexultiBrexpiprazole | 15 | $18,879 |
| Asenapine Maleate | 20 | $3,489 |
| Lamotrigine | 156 | $1,814 |
| Aripiprazole | 20 | $1,294 |
| Trazodone Hcl | 59 | $688 |
| Propranolol Hcl | 27 | $426 |
| Clonazepam | 47 | $348 |
| Quetiapine Fumarate | 26 | $286 |
| Prazosin Hcl | 18 | $247 |
| Hydroxyzine Hcl | 15 | $229 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $120 |
| Escitalopram Oxalate | 13 | $47 |
| Alprazolam | 14 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $31,089 | $101,36364 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $15,587 | $18,87915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 103 psychiatric/mental health providers in Hawaii.
Other psychiatric/mental health in Honolulu
- David GuoHonolulu$5K
- Christopher AtenHonolulu$4K
- Claire RauschHonolulu$3K
- Kesha MimmsHonolulu$3K
- Soonja TyrrellHonolulu$2K
- Sondra Leiggi BrandonHonolulu$2K
- Colleen AlfordHonolulu$2K
- Doris MukisaHonolulu$2K
- Luke XavierHonolulu$2K
- George MackelHonolulu$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.